Page 3 - சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail WASHINGTON, D.C., (April 28, 2021) - Two new studies, presented today as late-breaking clinical science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions, provide new treatment insights for cardiogenic shock (CS) patients. A study of the SCAI cardiogenic shock stages consensus document confirms the accuracy of the shock classification. In addition, an analysis of the National Cardiogenic Shock Initiative demonstrates use of a shock protocol emphasizing early use of mechanical circulatory support may lead to improved survival for patients with CS. CS is a rare, life-threatening condition in which the heart stops pumping enough blood to supply the vital organs of the body, and is the most common cause of death in patients with acute myocardial infarction (AMI). Despite advancements in pharmacological, mechanical and clinical interventions, the overall in-hospital mortality rate for patients with CS is 39%. For patients 75 years an

United statesJacob jentzerSociety for cardiovascular angiography interventionsHenry ford health system in detroitSociety for cardiovascular angiographyNational cardiogenic shock initiativeCardiovascular angiographyStages consensusBabar basirHenry ford health systemஒன்றுபட்டது மாநிலங்களில்சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள்ஹென்றி ஃபோர்ட் ஆரோக்கியம் அமைப்பு இல் டெட்ராய்ட்சமூகம் க்கு இருதய ஆஞ்சியோகிராபிஇருதய ஆஞ்சியோகிராபிஹென்றி ஃபோர்ட் ஆரோக்கியம் அமைப்பு